High Performance Liquid Chromatography (HPLC) Market Size, Share, Opportunities, And Trends By Product (Instruments, Consumables, Accessories), By Application (Manufacturing, Research, Law Enforcement, Medical, Others), And By Geography - Forecasts From 2025 To 2030

  • Published: August 2025
  • Report Code: KSI061610974
  • Pages: 149
Excel format icon PDF format icon PowerPoint format icon

High Performance Liquid Chromatography (HPLC) Market Size:

The High Performance Liquid Chromatography (HPLC) Market is expected to grow from USD 6.492 billion in 2025 to USD 8.090 billion in 2030, at a CAGR of 4.50%.

High-Performance Liquid Chromatography (HPLC) is a technique that helps in separating and identifying components in a mixture. Ongoing research and development are contributing to expanding the application of HPLC applications in the medical, research, and manufacturing sectors. Moreover, the high sensitivity and accuracy of HPLC endorse its increasing adoption by law enforcement agencies for detecting performance-enhancement drugs in urine, thereby augmenting the market growth. HPLC tests are gaining prominence for drug approvals as many countries have started focusing on using this technology. Other factors such as the growing popularity of the LC-MS technique and surging life sciences R&D spending are also propelling the HPLC market growth. However, high-cost equipment will be a key challenge to market growth over the forecast period. Manufacturers are increasingly focusing on developing improved technologies that can help researchers with high-quality analysis. This will push the HPLC market growth upwards over the next five years. Moreover, developing economies like China and India are expected to create numerous opportunities for HPLC equipment vendors over the projected period. 

High Performance Liquid Chromatography (HPLC) Market Segmentation Analysis:

  • By Product

The instrument segment accounted for a notable market share owing to the increasing use of HPLC equipment for analysis across various sectors. However, the consumables segment is expected to grow at a high rate over the projected period. The growth is majorly driven by technological advancements in the HPLC for consumables. The growing investments in the healthcare sector and expanding importance of HPLC in drug approval are significantly contributing to the segment’s growth.

  • By Geography

Geographically, North America accounted for the major market share in 2016 and will remain a key regional market over the forecasted period. The extensive R&D spending in the United States is the primary factor boosting this regional market growth. Moreover, the flourishing pharmaceuticals industry in Canada is significantly contributing to the high North American regional market share. However, Asia Pacific is projected to witness high growth over the projected period owing to high demand for these systems from China and India, because of increasing investments by the government and private players in the pharmaceuticals and research sector.   

High Performance Liquid Chromatography (HPLC) Market Competitive Insights:

The major players discussed in the report include Shimadzu Corporation, Agilent Technologies, Phenomenex, Thermo Fisher Scientific, Waters Corporation, Jasco, PerkinElmer, Novasep, Bio-Rad Laboratories, and Gilson.

The global HPLC market is dominated by a few players owing to their capability to invest in continuous research and development. Moreover, the need for skilled labor and knowledge coupled with high initial investment restricts the entry of new entrants which further enhances the position of existing players.

Segmentation

The High-Performance Liquid Chromatography market has been segmented by product, application, and geography.  

  • By Product
    • Instruments
    • Consumables
    • Accessories
  • By Application
    • Clinical Research
    • Diagnostic
    • Forensic
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
      • Others
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Others
    • Asia Pacific
      • Japan
      • China
      • South Korea
      • India
      • Others

1. EXECUTIVE SUMMARY 

2. MARKET SNAPSHOT

2.1. Market Overview

2.2. Market Definition

2.3. Scope of the Study

2.4. Market Segmentation

3. BUSINESS LANDSCAPE 

3.1. Market Drivers

3.2. Market Restraints

3.3. Market Opportunities 

3.4. Porter’s Five Forces Analysis

3.5. Industry Value Chain Analysis

3.6. Policies and Regulations 

3.7. Strategic Recommendations 

4. TECHNOLOGICAL OUTLOOK 

5. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MARKET BY PRODUCT

5.1. Introduction

5.2. Instruments

5.3. Consumables

5.4. Accessories

6. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MARKET BY APPLICATION

6.1. Introduction

6.2. Clinical Research

6.3. Diagnostic 

6.4. Forensic 

6.5. Others

7. HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) MARKET BY GEOGRAPHY

7.1. Introduction

7.2. North America

7.2.1. United States

7.2.2. Canada

7.2.3. Mexico

7.3. South America

7.3.1. Brazil 

7.3.2. Argentina

7.3.3. Others

7.4. Europe

7.4.1. Germany

7.4.2. France

7.4.3. United Kingdom

7.4.4. Others

7.5. Middle East & Africa

7.5.1. Saudi Arabia

7.5.2. UAE

7.5.3. Others

7.6. Asia Pacific

7.6.1. China

7.6.2. Japan 

7.6.3. South Korea

7.6.4. India

7.6.5. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis

8.2. Market Share Analysis

8.3. Mergers, Acquisitions, Agreements, and Collaborations

8.4. Competitive Dashboard

9. COMPANY PROFILES

9.1. Shimadzu Corporation

9.2. Agilent Technologies

9.3. Thermo Fisher Scientific

9.4. Waters Corporation

9.5. Jasco

9.6. PerkinElmer

9.7. Novasep 

9.8. Bio-Rad Laboratories

9.9. Gilson 

9.10. Danaher Corporation

9.11. Hitachi, Ltd.

9.12. Merck KGaA

10. APPENDIX

10.1. Currency 

10.2. Assumptions

10.3. Base and Forecast Years Timeline

10.4. Key benefits for the stakeholders

10.5. Research Methodology 

10.6. Abbreviations 

LIST OF FIGURES

LIST OF TABLES

 

Shimadzu Corporation

Agilent Technologies

Thermo Fisher Scientific

Waters Corporation

Jasco

PerkinElmer

Novasep 

Bio-Rad Laboratories

Gilson 

Danaher Corporation

Hitachi, Ltd.

Merck KGaA